Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1975-12-10
1981-06-30
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424177, 424183, 424319, 424335, A61K 3514, A61K 3700, A61K 31725, A61K 31195
Patent
active
042762847
ABSTRACT:
Certain ulcers and disease conditions resulting in tissue destruction, such as those found near the cornea of the eye, and those found in the stomach, and damaged joint tissue of rheumatoid arthritis, have been found to be caused by the enzyme, collagenase. A collagenase inhibitor, such as cysteine, ethylene diamine tetraacetic acid (or sodium ethylene diamine tetraacetate), or combinations of these collagenase inhibitors, are used to treat such ulcers and to inhibit further formation thereof.
REFERENCES:
Arch. Ophthal., vol. 35, Apr. 1946, pp. 423-449; vol. 52, 1954, pp. 846-851; vol. 54 (1955) pp. 931-939.
Am. J. Ophthal. 42 527(1956); vol. 42 part II (1956), pp. 167-181.
Chemical Abstracts, vol. 71 (1969), Paragraph 68715h.
Laubscher Lawrence E.
Waddell Frederick E.
LandOfFree
Prevention of collagenase induced disease by treatment with coll does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of collagenase induced disease by treatment with coll, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of collagenase induced disease by treatment with coll will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2434302